CHIESI.NO KEYWORD DENSITY CHECKER

Total words: 1385 | 2-word phrases: 357 | 3-word phrases: 387 | 4-word phrases: 395

PAGE INFO

Title Try to keep the title under 60 characters (13 characters)
Chiesi Pharma
Description Try to keep the meta description between 50 - 160 characters (181 characters)
Chiesi er et internasjonalt selskap med hovedkontor i Parma i Italia. Vi har 80 års erfaring i og et sterkt fokus på forskning og utvikling, fremstilling av innovative legemidler.
Keywords Meta keywords are not recommended anymore (0 characters)
H1 No H1 tag on the page (0 characters)

ONE WORD PHRASES 246 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1chiesi3815.45%
2sjeldne93.66%
3og83.25%
4btnareepng83.25%
5sykdommer72.85%
6dummypng52.03%
7slidebg152.03%
8neonatologi52.03%
9spesialbehandling52.03%
10pharmaceuticals52.03%

TWO WORD PHRASES 357 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1chiesi pharma71.96%
2sjeldne sykdommer51.40%
3slidebg1 dummypng51.40%
4chiesi pharmaceutical30.84%
5chiesi pharmaceuticals30.84%
6hos chiesi30.84%
7nordisk bærekraftsrapport20.56%
8flere tiår20.56%
9neonatologi i20.56%
10iconneonatobpng neonatologi20.56%
11btnareepng iconneonatobpng20.56%
12  btnareepng20.56%
13respirasjon  20.56%
14nyheter og20.56%
15Års og20.56%
16chiesi pharmas20.56%
17chiesi vært20.56%
18vår b20.56%
19chiesi globalt20.56%
20vår historie20.56%

THREE WORD PHRASES 387 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1vært dedikert til20.52%
2chiesi vært dedikert20.52%
3btnareepng icspcaoffpng spesialbehandling20.52%
4chiesi pharma ab20.52%
5brukes ved ulike20.52%
6diagnoser brukes ved20.52%
7transplantasjon av solide20.52%
8av solide btnareepng20.52%
9sykdommer eller sjeldne20.52%
10sjeldne sykdommer eller20.52%
11sykdommer sjeldne sykdommer20.52%
12dedikert til btnareepng20.52%
13nyre og leversvikt20.52%
14og leversvikt –20.52%
15har chiesi vært20.52%
16btnareepng iconneonatobpng neonatologi20.52%
17least 3 characters20.52%
18at least 320.52%
19respirasjon   btnareepng20.52%
20enter at least20.52%
21chiesi pÅ internett20.52%
22iconneonatobpng neonatologi i20.52%
23vår b corpsertifisering20.52%
242024 sustainability downloadpng10.26%
25pdf version other10.26%
26© 2024 chiesi10.26%
27pluspng © 202410.26%
28publications pluspng ©10.26%
29other publications pluspng10.26%
30sustainability downloadpng download10.26%

FOUR WORD PHRASES 395 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1vært dedikert til btnareepng20.51%
2btnareepng iconneonatobpng neonatologi i20.51%
3nyre og leversvikt –20.51%
4diagnoser brukes ved ulike20.51%
5sjeldne sykdommer eller sjeldne20.51%
6sykdommer sjeldne sykdommer eller20.51%
7chiesi vært dedikert til20.51%
8har chiesi vært dedikert20.51%
9transplantasjon av solide btnareepng20.51%
10enter at least 320.51%
11at least 3 characters20.51%
12euro i den första10.25%
13av solide btnareepng icspcaoffpng10.25%
14solide btnareepng icspcaoffpng spesialbehandling10.25%
15av solide btnareepng chiesi10.25%
16carbon minimal inhalers reach10.25%
17minimal inhalers reach new10.25%
18inhalers reach new btnricercapng10.25%
19reach new btnricercapng chiesi10.25%
20new btnricercapng chiesi investerar10.25%
21btnricercapng chiesi investerar 35010.25%
22telefon 46 8 75310.25%
23stockholm telefon 46 810.25%
24miljoner euro i den10.25%
2534 111 22 stockholm10.25%
26kyrkogata 34 111 2210.25%
27111 22 stockholm telefon10.25%
28norra kyrkogata 34 11110.25%
29chiesi pharma ab klara10.25%
302024 chiesi pharma ab10.25%
31© 2024 chiesi pharma10.25%
32pluspng © 2024 chiesi10.25%
33publications pluspng © 202410.25%
34other publications pluspng ©10.25%
35den första btnricercapng publications10.25%
36version other publications pluspng10.25%
37pdf version other publications10.25%
382024 sustainability downloadpng download10.25%
39– transplantasjon av solide10.25%
4022 stockholm telefon 4610.25%

EXTERNAL LINKS

# URL Whois Check
1http://www.chiesi.com Whoischiesi.com
2 https://www.chiesipharma.se/img/annual_report/documenti/44_sustainability-reporting-2023_eng.pdf Whoischiesipharma.se